NORTHWEST BIOTHERAPEUTICS, INC., and The Bank of New York Mellon, as Trustee INDENTURE Dated as of August 19, 2014 5.00% Convertible Senior Notes due 2017Indenture • August 25th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of August 19, 2014, between Northwest Biotherapeutics, Inc., a Delaware corporation, as issuer (hereinafter sometimes called the “Company”, as more fully set forth in Section 1.01), and The Bank of New York Mellon, a national banking association, as trustee (hereinafter sometimes called the “Trustee”, as more fully set forth in Section 1.01).
PLEDGE AND ESCROW AGREEMENTPledge and Escrow Agreement • August 25th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
THIS PLEDGE AND ESCROW AGREEMENT (this “Agreement”), dated as of August 19, 2014, is by and among Northwest Biotherapeutics, Inc. (the “Company”), as pledgor, The Bank of New York Mellon, as trustee under the Indenture referred to below (the “Trustee”), and The Bank of New York Mellon, in its capacity as securities intermediary and escrow agent (the “Escrow Agent”).
